Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 18-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 24)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
17-Apr-14Pechala's ReportsLubomir PechalaNXSTAGE MEDICAL INC (NXTM) - REPORT FOR ACTIVE TRADERS1$25  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for NXTM11$25  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical Products17$49  View Abstract
17-Apr-14New Constructs, LLCN/ANXTM: Due Diligence Review: Forensic Earnings and Valuation5$25  View Abstract
16-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Nxstage Medical, Inc.42$75  View Abstract
13-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Nextcom Ltd.42$75  View Abstract
12-Apr-14Alpha Street ResearchHunter OrrNXTM - NxStage Medical Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report9$24  View Abstract
12-Apr-14S&P Capital IQ Quantitative ReportN/ANxStage Medical11$126.50  View Abstract
12-Apr-14Reuters Investment ProfileN/ANextcom Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
12-Apr-14Pechala's ReportsFrantisek PechalaNXSTAGE MEDICAL INC (NXTM) 12-months forecast1$15  View Abstract
Next 14

Independent Reports (Showing 1 to 10 of 24)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
17-Apr-14Pechala's ReportsLubomir PechalaNXSTAGE MEDICAL INC (NXTM) - REPORT FOR ACTIVE TRADERS1$25View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for NXTM11$25View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical Products17$49View Abstract
17-Apr-14New Constructs, LLCN/ANXTM: Due Diligence Review: Forensic Earnings and Valuation5$25View Abstract
16-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Nxstage Medical, Inc.42$75View Abstract
13-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Nextcom Ltd.42$75View Abstract
12-Apr-14Alpha Street ResearchHunter OrrNXTM - NxStage Medical Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report9$24View Abstract
12-Apr-14S&P Capital IQ Quantitative ReportN/ANxStage Medical11$126.50View Abstract
12-Apr-14Reuters Investment ProfileN/ANextcom Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
12-Apr-14Pechala's ReportsFrantisek PechalaNXSTAGE MEDICAL INC (NXTM) 12-months forecast1$15View Abstract
Next 14

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.